{"id":"https://openalex.org/W7128028898","doi":"https://doi.org/10.1093/eurheartj/ehaf784.3641","title":"Novel preventive cardiology clinic associated with reduced risk of recurrent major adverse cardiovascular events for patients with prior acute coronary syndrome","display_name":"Novel preventive cardiology clinic associated with reduced risk of recurrent major adverse cardiovascular events for patients with prior acute coronary syndrome","publication_year":2025,"publication_date":"2025-11-01","ids":{"openalex":"https://openalex.org/W7128028898","doi":"https://doi.org/10.1093/eurheartj/ehaf784.3641"},"language":"en","primary_location":{"id":"doi:10.1093/eurheartj/ehaf784.3641","doi":"https://doi.org/10.1093/eurheartj/ehaf784.3641","is_oa":false,"landing_page_url":"https://doi.org/10.1093/eurheartj/ehaf784.3641","pdf_url":null,"source":{"id":"https://openalex.org/S181568219","display_name":"European Heart Journal","issn_l":"0195-668X","issn":["0195-668X","1522-9645"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Heart Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5125214534","display_name":"J Y Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J Y Chen","raw_affiliation_strings":["University of Birmingham, Institute of Cardiovascular Sciences , Birmingham ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Birmingham, Institute of Cardiovascular Sciences , Birmingham ,","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125170939","display_name":"N R Desai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"N R Desai","raw_affiliation_strings":["University of Birmingham, Institute of Cardiovascular Sciences , Birmingham ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Birmingham, Institute of Cardiovascular Sciences , Birmingham ,","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087626274","display_name":"Nazish Khan","orcid":"https://orcid.org/0000-0003-4483-7390","observed_orcids":["https://orcid.org/0000-0003-4483-7390"]},"institutions":[{"id":"https://openalex.org/I1308923049","display_name":"University Hospitals Birmingham NHS Foundation Trust","ror":"https://ror.org/014ja3n03","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1308923049"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"N Khan","raw_affiliation_strings":["University Hospitals Birmingham NHS Foundation Trust, Department of Cardiology , Birmingham ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospitals Birmingham NHS Foundation Trust, Department of Cardiology , Birmingham ,","institution_ids":["https://openalex.org/I1308923049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013943027","display_name":"Sophia Khattak","orcid":"https://orcid.org/0000-0002-8683-5433","observed_orcids":["https://orcid.org/0000-0002-8683-5433"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S Khattak","raw_affiliation_strings":["University of Birmingham, Institute of Cardiovascular Sciences , Birmingham ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Birmingham, Institute of Cardiovascular Sciences , Birmingham ,","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086194417","display_name":"Sudhakar George","orcid":"https://orcid.org/0000-0002-2871-2363","observed_orcids":["https://orcid.org/0000-0002-2871-2363"]},"institutions":[{"id":"https://openalex.org/I1308923049","display_name":"University Hospitals Birmingham NHS Foundation Trust","ror":"https://ror.org/014ja3n03","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1308923049"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S George","raw_affiliation_strings":["University Hospitals Birmingham NHS Foundation Trust, Department of Cardiology , Birmingham ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospitals Birmingham NHS Foundation Trust, Department of Cardiology , Birmingham ,","institution_ids":["https://openalex.org/I1308923049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038300932","display_name":"John Townend","orcid":"https://orcid.org/0000-0002-5881-5806","observed_orcids":["https://orcid.org/0000-0002-5881-5806"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J Townend","raw_affiliation_strings":["University of Birmingham, Institute of Cardiovascular Sciences , Birmingham ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Birmingham, Institute of Cardiovascular Sciences , Birmingham ,","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043982558","display_name":"Mark Roland Thomas","orcid":"https://orcid.org/0000-0001-7048-7764","observed_orcids":["https://orcid.org/0000-0001-7048-7764"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M R Thomas","raw_affiliation_strings":["University of Birmingham, Institute of Cardiovascular Sciences , Birmingham ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Birmingham, Institute of Cardiovascular Sciences , Birmingham ,","institution_ids":["https://openalex.org/I79619799"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5240,"currency":"EUR","value_usd":5922},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.56014702,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"46","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.5976999998092651,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.5976999998092651,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10292","display_name":"Acute Myocardial Infarction Research","score":0.2410999983549118,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11083","display_name":"Cardiac Health and Mental Health","score":0.07199999690055847,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/secondary-prevention","display_name":"secondary prevention","score":0.8880000114440918},{"id":"https://openalex.org/keywords/acute-coronary-syndrome","display_name":"acute coronary syndrome","score":0.9729999899864197},{"id":"https://openalex.org/keywords/major-adverse-cardiovascular-events","display_name":"major adverse cardiovascular events","score":0.9869999885559082},{"id":"https://openalex.org/keywords/pcsk9-inhibitors","display_name":"PCSK9 inhibitors","score":0.9409999847412109},{"id":"https://openalex.org/keywords/ezetimibe","display_name":"ezetimibe","score":0.9160000085830688},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9800000190734863},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8709999918937683},{"id":"https://openalex.org/keywords/dual-antithrombotic-therapy","display_name":"dual antithrombotic therapy","score":0.8939999938011169},{"id":"https://openalex.org/keywords/rivaroxaban","display_name":"rivaroxaban","score":0.8899999856948853},{"id":"https://openalex.org/keywords/ticagrelor","display_name":"ticagrelor","score":0.9959999918937683},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.6769999861717224},{"id":"https://openalex.org/keywords/cardiovascular-mortality","display_name":"cardiovascular mortality","score":0.4300000071525574},{"id":"https://openalex.org/keywords/ischemic-stroke","display_name":"ischemic stroke","score":0.6840000152587891},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.8009999990463257}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9912999868392944},{"id":"https://openalex.org/C2777698277","wikidata":"https://www.wikidata.org/wiki/Q266018","display_name":"Acute coronary syndrome","level":3,"score":0.792900025844574},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6172000169754028},{"id":"https://openalex.org/C2777015399","wikidata":"https://www.wikidata.org/wiki/Q4775337","display_name":"Antithrombotic","level":2,"score":0.5859000086784363},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5196999907493591},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4851999878883362},{"id":"https://openalex.org/C2778213512","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Coronary artery disease","level":2,"score":0.45750001072883606},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4189000129699707},{"id":"https://openalex.org/C2779256446","wikidata":"https://www.wikidata.org/wiki/Q33959","display_name":"Nice","level":2,"score":0.4142000079154968},{"id":"https://openalex.org/C3020110884","wikidata":"https://www.wikidata.org/wiki/Q695416","display_name":"Outpatient clinic","level":2,"score":0.40860000252723694},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3928000032901764},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.3619000017642975},{"id":"https://openalex.org/C3019417119","wikidata":"https://www.wikidata.org/wiki/Q1773974","display_name":"Secondary prevention","level":2,"score":0.3580999970436096},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3474999964237213},{"id":"https://openalex.org/C2909112448","wikidata":"https://www.wikidata.org/wiki/Q721432","display_name":"Platelet aggregation inhibitor","level":3,"score":0.33320000767707825},{"id":"https://openalex.org/C2780739214","wikidata":"https://www.wikidata.org/wiki/Q6723023","display_name":"Mace","level":4,"score":0.3312000036239624},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.3310999870300293},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.3278999924659729},{"id":"https://openalex.org/C2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","level":4,"score":0.3111000061035156},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3098999857902527},{"id":"https://openalex.org/C2909938374","wikidata":"https://www.wikidata.org/wiki/Q311213","display_name":"Glycated haemoglobin","level":4,"score":0.2937000095844269},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.2904999852180481},{"id":"https://openalex.org/C2779464278","wikidata":"https://www.wikidata.org/wiki/Q7317735","display_name":"Revascularization","level":3,"score":0.27959999442100525},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.27129998803138733},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.2615000009536743},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.25690001249313354},{"id":"https://openalex.org/C2780724011","wikidata":"https://www.wikidata.org/wiki/Q1295316","display_name":"Emergency department","level":2,"score":0.2533999979496002},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.2524000108242035}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/eurheartj/ehaf784.3641","doi":"https://doi.org/10.1093/eurheartj/ehaf784.3641","is_oa":false,"landing_page_url":"https://doi.org/10.1093/eurheartj/ehaf784.3641","pdf_url":null,"source":{"id":"https://openalex.org/S181568219","display_name":"European Heart Journal","issn_l":"0195-668X","issn":["0195-668X","1522-9645"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Heart Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4413164101","https://openalex.org/W4377984695","https://openalex.org/W2751780247","https://openalex.org/W6940697927","https://openalex.org/W3134762205","https://openalex.org/W4319063514","https://openalex.org/W2891938588","https://openalex.org/W2372483774","https://openalex.org/W2909114116","https://openalex.org/W2889456268"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Despite":[2],"conventional":[3],"treatment,":[4],"up":[5,51],"to":[6,45,57,65,146,170,240,381],"a":[7,42,52,120,218,398,406],"third":[8],"of":[9,18,36,60,101,161,221,246,313,323,372,402],"patients":[10,102,136,143,148,162,208,257,315],"experience":[11],"recurrent":[12],"cardiovascular":[13,99,188,193,403],"events":[14,189,404],"within":[15],"five":[16],"years":[17],"an":[19,293],"acute":[20,31],"coronary":[21,223,335],"syndrome":[22],"(ACS).[1]":[23],"Clinical":[24],"efforts":[25],"often":[26],"focus":[27],"on":[28],"treating":[29],"the":[30,105,154,159,213,241,259,318,327,351,377],"event,":[32],"although":[33],"aggressive":[34],"use":[35,59,371],"new":[37,106,373],"risk-reducing":[38,62],"medications":[39,74],"also":[40],"offers":[41],"promising":[43],"strategy":[44],"improve":[46],"long-term":[47,87,282,390],"outcomes.":[48],"We":[49,157,172],"set":[50],"specialist":[53,107],"secondary":[54,123],"prevention":[55,108,124,141,214,260,319,352,378],"clinic":[56,109,126,142,215,243,320,329,353,379],"maximise":[58],"all":[61],"treatments":[63,80,166,251,375,388],"according":[64,169],"ESC":[66,247],"and":[67,86,140,178,197,204,235,248,290,321,338,389],"NICE":[68,249],"guidelines.":[69,171],"These":[70],"included":[71,263],"recent":[72],"lipid-lowering":[73,385],"(ezetimibe":[75],"and/or":[76],"PCSK9":[77,271],"inhibitors),":[78],"diabetes":[79,233,387],"(SGLT2":[81],"inhibitors":[82,272],"or":[83,93],"GLP1":[84],"agonists)":[85],"dual":[88,283,391],"antithrombotic":[89,284,392],"therapy":[90,285],"(low-dose":[91],"rivaroxaban":[92],"ticagrelor).":[94],"Purpose":[95],"This":[96,262,394],"study":[97],"compared":[98,145,239,380],"outcomes":[100],"seen":[103,149],"in":[104,112,132,150,255,258,311,317,326,376],"with":[110,356,397],"those":[111],"standard":[113,130,151,242,328,382],"post-ACS":[114],"clinics.":[115],"Methods":[116],"In":[117],"October":[118,202],"2020,":[119],"novel":[121],"pilot":[122],"cardiology":[125],"was":[127,185,252,303,354,369,395],"established":[128],"alongside":[129],"clinics":[131,152],"two":[133],"hospitals.":[134],"All":[135],"had":[137,217],"prior":[138],"ACS,":[139],"were":[144,209,340],"similar":[147],"during":[153],"same":[155],"period.":[156,408],"determined":[158],"percentage":[160],"who":[163],"received":[164],"recommended":[165],"when":[167],"eligible":[168,256],"assessed":[173],"survival":[174],"using":[175],"Kaplan-Meier":[176],"curves":[177],"multivariate":[179],"Cox":[180],"regression.":[181],"The":[182,307],"primary":[183,308],"endpoint":[184],"major":[186],"adverse":[187],"(MACE),":[190],"defined":[191],"as":[192],"death,":[194],"non-fatal":[195],"MI":[196],"ischaemic":[198],"stroke.":[199],"Results":[200],"Between":[201],"2020":[203],"June":[205],"2022,":[206],"353":[207],"included.":[210],"At":[211],"baseline,":[212],"group":[216],"higher":[219,254],"prevalence":[220],"multivessel":[222,334],"artery":[224,336],"disease":[225,337],"(p=0.003),":[226],"hypertension":[227],"(p=0.002),":[228],"hypercholesterolaemia":[229,339],"(p=0.046),":[230],"type":[231],"2":[232],"(p<0.001)":[234],"glycated":[236],"haemoglobin":[237],"(p=0.013)":[238],"group.":[244],"Use":[245],"guideline-recommended":[250,374],"significantly":[253],"clinic.":[261],"SGLT2":[264],"inhibitors/GLP1":[265],"agonists":[266],"(92%":[267,286],"vs":[268,274,279,287,297],"17%;":[269],"p<0.001),":[270,281],"(100%":[273],"27%;":[275],"p=0.03),":[276],"ezetimibe":[277],"(90%":[278],"24%;":[280],"4%;":[288],"p<0.001)":[289],"statins":[291],"at":[292],"optimal":[294],"dose":[295],"(99%":[296],"80%;":[298],"p<0.001).":[299],"Median":[300],"follow-up":[301],"time":[302],"1232":[304],"(1087\u20131352)":[305],"days.":[306],"outcome":[309],"occurred":[310],"14":[312],"116":[314],"(12%)":[316],"49":[322],"237":[324],"(21%)":[325],"(Log-Rank":[330],"p=0.04).":[331],"Cerebrovascular":[332],"disease,":[333],"independent":[341],"predictors":[342],"for":[343,347,364],"MACE":[344,358],"after":[345,362],"adjusting":[346,363],"other":[348,365],"predictors.":[349,366],"Attending":[350],"associated":[355,396],"reduced":[357],"(HR":[359],"0.53;":[360],"p=0.04)":[361],"Conclusion":[367],"There":[368],"improved":[370],"clinics,":[383],"including":[384],"medications,":[386],"therapy.":[393],"47%":[399],"lower":[400],"rate":[401],"over":[405],"3-year":[407]},"counts_by_year":[],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2026-02-07T00:00:00"}